Search

Author/Creator Sancho, J.-M.

1. P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS. (23rd June 2022)

Authors:
Sancho, J.-M.; Lopez-Guillermo, A.; Abrisqueta, P.; Kumar, A.; Cordoba, R.; Tani, M.; Zhao, W.; Rappold, E.; Langmuir, P.; Mims, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102). (23rd June 2022)

Authors:
Hamadani, M.; Coleman, M.; Boccia, R.; Duras, J.; Hutchings, M.; Zinzani, P. L.; Cordoba, R.; Oreiro, M. B.; Williams, V.; Stouffs, M.; Langmuir, P.; Sancho, J.-M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
994
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA. (23rd June 2022)

Authors:
McMillan, A.; Haioun, C.; Sancho, J.-M.; Viardot, A.; Rodriguez Izquierdo, A.; Donato Martin, E. M.; García-Sancho, A. M.; Sandoval-Sus, J.; Tilly, H.; Vandenberghe, E.; Hirata, J.; Choudhry, P.; Chang, Y. M.; Musick, L.; Matasar, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1075
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search